High-throughput sequencing method for hypertension treatment drug related genes and application thereof
A technology for the treatment of drugs and hypertension, applied in the determination/examination of microorganisms, biochemical equipment and methods, DNA/RNA fragments, etc., which can solve the problems of limited drug types, low flexibility, and low throughput
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0077] Detection of drug-related genes for hypertension treatment based on Illumina sequencing platform
[0078] Reagents: NEBNext Ultra II Q5 Master Mix (New England Biolabs), Agencourt AMPureXP (Beckman Coulter), QubitdsDNA HS Assay Kit (ThermoFisher), MagMAX TM DNA Multi-Sample Kit (ThermoFisher), primers for gene amplification related to antihypertensive drugs (one gene), I5 end adapter primer (one gene), I7 end adapter primer (one gene)
[0079] 1. Genomic DNA extraction and concentration detection of the sample to be tested:
[0080] Take three hypertensive patients: sample 1, sample 2, sample 3 anticoagulant blood samples, use MagMAX TM DNA Multi-Sample Kit, follow the kit instructions for DNA extraction. For the extracted genomic DNA, the concentration of the sample was quantitatively detected by Qubit. The result is as follows:
[0081] sample sample 1 sample 2 sample 3 Concentration (ng / μL) 46 39 25
[0082] 2. Multiplex PCR amplifi...
Embodiment 2
[0126] Three hypertensive patients were taken: sample 1, sample 2, and sample 3 anticoagulant blood samples were tested, and the operation steps were operated according to Example 1. The following results were obtained after sequencing on the Illumina sequencing platform and data analysis:
[0127]
[0128]
[0129] Losartan is an angiotensin II receptor antagonist and is a commonly used antihypertensive drug. The protein encoded by CYP2C9 belongs to the CYP450 family of drug-metabolizing enzymes, which can catalyze the metabolism of losartan into the active product EXP-3174 in vivo, thereby exerting the antihypertensive effect. Some polymorphisms of CYP2C9 gene affect the production of losartan active product EXP-3174, and then affect the antihypertensive effect. Individuals carrying the CYP2C9*3 (rs1057910, A1075C, Ile359Leu) allele had reduced production of EXP-3174 and reduced metabolic rate of losartan after administration of losartan. Oral administration of a sing...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com